Guangdong Association Of Clinical Trials
Clinical trials sponsored by Guangdong Association Of Clinical Trials, explained in plain language.
-
Major lung cancer drug study looks at Real-World results
Disease control Not yet recruitingThis study looks back at medical records to see how well the drug IBI351 works and how safe it is for Chinese patients with a specific type of advanced lung cancer (KRAS G12C mutation). Researchers will analyze data from 600 patients who took the drug between August 2024 and Augu…
Sponsor: Guangdong Association of Clinical Trials • Aim: Disease control
Last updated Apr 04, 2026 08:20 UTC
-
New drug duo aims to Re-Ignite fight against stubborn lung cancer
Disease control Not yet recruitingThis study is testing whether combining two drugs, chidamide and ivonescimab, can help control advanced non-small cell lung cancer that has started growing again after initially responding to immunotherapy. It will involve about 32 adults whose tumors show high levels of a specif…
Phase: PHASE2 • Sponsor: Guangdong Association of Clinical Trials • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for tough lung cancers: four-drug combo aims to shrink tumors when other treatments fail
Disease control Not yet recruitingThis study is testing whether a combination of four drugs can help control advanced lung cancer that has specific genetic changes and has stopped responding to standard targeted pills. About 61 adults with a high level of a protein called PD-L1 in their tumors will receive the dr…
Phase: PHASE2 • Sponsor: Guangdong Association of Clinical Trials • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC